VC
Vaccinex, Inc.
VCNX · OTC
$1.00 +0.00% (+$0.00)
1M -4.76%
Market Cap $2.68M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
40 /100
Fair P/S 4.45x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 12.59%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 95.51%
Net margin 3,100.50%
FCF margin 2,696.84%
Quality
61 /100
Average ROIC 760.66%
ROA 717.80%
Asset turnover 0.23x
Debt
3 /100
High Current ratio 0.50x
Int. coverage -620.13x
Debt/Equity N/A
Stability
52 /100
Moderate Beta 0.68x
Rev. volatility 299.19%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VCNX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Maurice Zauderer
Employees
25
Headquarters
Rochester
Upcoming events
16 NOV
Earnings
Upcoming earnings report